BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 10661481)

  • 1. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
    Canavese C; Grill A; Decostanzi E; Maddalena E; Barbieri S; Martina G; Fop F; Buglione E; Grechi D; David O; Saitta M; Piccoli G
    Clin Nephrol; 2000 Jan; 53(1):42-7. PubMed ID: 10661481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.
    Baldus M; Walter H; Thies K; Anders C; Stein M; Hellstern P; Brass H
    Clin Nephrol; 1998 Mar; 49(3):186-92. PubMed ID: 9543601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A; Karkar A; Abdelrahman M
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc protoporphyrin/heme as an indicator of iron status in NICU patients.
    Juul SE; Zerzan JC; Strandjord TP; Woodrum DE
    J Pediatr; 2003 Mar; 142(3):273-8. PubMed ID: 12640375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ferritin concentration: a reliable guide to iron overload in uremic and hemodialyzed patients.
    Aljama P; Ward MK; Pierides AM; Eastham EJ; Ellis HA; Feest TG; Conceicao S; Kerr DN
    Clin Nephrol; 1978 Sep; 10(3):101-4. PubMed ID: 699405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron metabolism in rhEPO-treated hemodialysis patients.
    Schaefer RM; Bahner U
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S65-8. PubMed ID: 10746809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
    Arndt U; Kaltwasser JP; Gottschalk R; Hoelzer D; Möller B
    Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
    Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
    J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
    Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH
    Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of postpartum iron supplementation on red cell and iron parameters in non-anaemic iron-deficient women: a randomised placebo-controlled study.
    Krafft A; Perewusnyk G; Hänseler E; Quack K; Huch R; Breymann C
    BJOG; 2005 Apr; 112(4):445-50. PubMed ID: 15777442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron sulfate supplementation decreases zinc protoporphyrin to heme ratio in premature infants.
    Miller SM; McPherson RJ; Juul SE
    J Pediatr; 2006 Jan; 148(1):44-8. PubMed ID: 16423596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M; Salopek S; Möller M; Schliesser J; Klooker P; Reddig J; Gansert U; Brass H
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron deficiency in the acute-phase reaction after open aortic surgery.
    Solis JV; Portero JL; Diaz J; Garcia R; Ligero JM; Vazquez E; Lodeiro C; Ballesteros L
    Vasc Endovascular Surg; 2006; 40(5):392-8. PubMed ID: 17038573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia.
    Schoorl M; Schoorl M; Nubé MJ; Bartels PC
    Clin Lab; 2006; 52(11-12):621-9. PubMed ID: 17175894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Red cell zinc protoporphyrin and its ratio to serum ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal failure on hemodialysis].
    Matuszkiewicz-Rowińska J; Ostrowski G; Niemczyk S; Przedlacki J; Wardyn K; Puka J; Włodarczyk D; Switalski M; Zakrzewska T; Ostrowski K
    Pol Arch Med Wewn; 2003 Jul; 110(1):703-10. PubMed ID: 14682204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of iron deficiency in infancy with iron-acetyl transferrin].
    Careddu P; Mirra N; D'Angelo E; Carnelli V
    Pediatr Med Chir; 1996; 18(2):155-60. PubMed ID: 8767577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of zinc protoporphyrin and hemoglobin concentrations in identifying iron deficiency in a group of low-income, preschool-aged children: practical implications of recent illness.
    Crowell R; Ferris AM; Wood RJ; Joyce P; Slivka H
    Pediatrics; 2006 Jul; 118(1):224-32. PubMed ID: 16818569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentration of ferritin, transferrin and iron as a markers of iron deficiency in healthy women in reproductive age].
    Chełchowska M; Laskowska-Klita T; Leibschang J
    Pol Merkur Lekarski; 2007 Jan; 22(127):25-7. PubMed ID: 17477085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc protoporphyrin, a useful parameter to address hyperferritinemia.
    Metzgeroth G; Schultheis B; Dorn-Beineke A; Hehlmann R; Hastka J
    Ann Hematol; 2007 May; 86(5):363-8. PubMed ID: 17333188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.